Evaluation of a Multiplex Assay for Estimation of HIV-1 Incidence
Open Access
- 22 May 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (5), e64201
- https://doi.org/10.1371/journal.pone.0064201
Abstract
Objectives Accurate methods of estimating HIV-1 incidence are critical for monitoring the status of the epidemic and the impact of prevention strategies. Although several laboratory-based tests have been developed strictly for this purpose, several limitations exist and improved methods or technologies are needed. We sought to further optimize a previously described bead-based, HIV-1-specific multiplex assay with the capability of measuring multiple immune responses for determining recent infection. Methods We refined the customized HIV-1 Bio-Plex assay by determining cutoffs and mean durations of recency (MDR), based on the reactivity to longitudinal seroconversion specimens (n = 1347) from 311 ART-naïve, HIV-1-infected subjects. False-recent rates (FRRs) were calculated for various long-term cohorts, including AIDS patients, individuals on ART, and subtype C specimens. Incidence was estimated for each individual assay analyte from a simulated population with a known incidence of 1%. For improved incidence estimates, multi-analyte algorithms based on combinations of 3 to 6 analytes were evaluated and compared to the performance of each individual analyte. Results The MDR for the six analytes varied from 164.2 to 279.4 days, while the multi-analyte algorithm MDRs were less variable with a minimum and maximum value of 228.4 and 277.9 days, respectively. The FRRs for the 7 multi-analyte algorithms evaluated in this study varied from 0.3% to 3.1%, in a population of ART-naïve, long-term individuals. All algorithms yielded improved incidence estimates as compared to the individual analytes, predicting an incidence of 0.95% to 1.02%. Conclusions The HIV-specific multiplex assay described here measures several distinct immune responses in a single assay, allowing for the consideration of multi-analyte algorithms for improved HIV incidence estimates.Keywords
This publication has 40 references indexed in Scilit:
- A New General Biomarker-based Incidence EstimatorEpidemiology, 2012
- Initial HIV-1 Antigen-Specific CD8 + T Cells in Acute HIV-1 Infection Inhibit Transmitted/Founder Virus ReplicationJournal of Virology, 2012
- Detection of Recent HIV-1 Infection Using a New Limiting-Antigen Avidity Assay: Potential for HIV-1 Incidence Estimates and Avidity Maturation StudiesPLOS ONE, 2012
- Characterization of Acute HIV-1 Infection in High-Risk Nigerian PopulationsThe Journal of Infectious Diseases, 2012
- Development and Characterization of a Bead-Based, Multiplex Assay for Estimation of Recent HIV Type 1 InfectionAIDS Research and Human Retroviruses, 2012
- More and Better Information to Tackle HIV Epidemics: Towards Improved HIV Incidence AssaysPLoS Medicine, 2011
- Dual Testing Algorithm of BED-CEIA and AxSYM Avidity Index Assays Performs Best in Identifying Recent HIV Infection in a Sample of Rwandan Sex WorkersPLOS ONE, 2011
- Assessment of Recent HIV-1 Infection by a Line Immunoassay for HIV-1/2 ConfirmationPLoS Medicine, 2007
- Appropriate calibration curve fitting in ligand binding assaysThe AAPS Journal, 2007
- Human Immunodeficiency Virus (HIV) Antibody Avidity Testing To Identify Recent Infection in Newly Diagnosed HIV Type 1 (HIV-1)-Seropositive Persons Infected with Diverse HIV-1 SubtypesJournal of Clinical Microbiology, 2007